D-Wave Quantum: Two Platforms, One Deadline, and a Federal Exit Door
Published on 09/16/2026 at 16:41 | Editorial boerse-global.deD-Wave Quantum is betting that a single conference stage in Maryland can do what two quarters of financial reporting have not: convince the market that its technology is ready for prime time. The quantum computing specialist confirmed this week that it will serve as a platinum sponsor of the Quantum World Congress 2026, running September 23–25 in College Park, with Chief Science Officer Dr. Robert Schoelkopf slated to deliver a plenary address on Friday the 25th.
His talk, titled "From Innovation to Utility: The Quantum Era Takes Shape with Two Platforms," is designed to show how the company's twin architectural bets — established annealing systems alongside superconducting gate-model machines — translate into paying commercial deployments. That dual-track strategy took on new weight after the January 2026 acquisition of Quantum Circuits Inc., which pushed D-Wave beyond its annealing roots. Management under CEO Alan Baratz has mapped out roadmaps targeting architectures of 10,000 qubits and, further out, 100,000 qubits.
Proof Points Beyond the Podium
There is at least one live reference case to point to. On August 18, Japan's NTT DOCOMO switched on a second production quantum application built on D-Wave technology. Running inside the carrier's live network, the solution cut location-registration signals by 65.3% during daily peak load and trimmed paging signals by 7.0%. For a sector still searching for evidence that experimental hardware delivers measurable operating gains, that deployment carries outsized rhetorical value.
The commercial mix is shifting too. In the second quarter, 62.4% of revenue came from commercial customers, with nearly half of that generated by companies on the Forbes Global 2000 list.
Washington's Money — and Its Exit Clause
Underpinning the development and scaling effort is public funding. Roughly a week ago, D-Wave finalized an agreement under the U.S. CHIPS and Science Act worth up to $100 million. The terms hand the U.S. Department of Commerce a non-controlling minority stake, and the arrangement permits the government to resell 7.1 million QBTS shares. D-Wave registered those shares on September 10. No proceeds flow to the company from any such sales, and the outstanding share count does not rise — but the registration puts a potential secondary supply of stock in plain view.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
Additional support has arrived from north of the border and from the research community: the National Research Council of Canada has provided funding, and the U.S. National Science Foundation contributed $1.57 million for the ERASE project.
The Order Book Versus the Income Statement
For all the strategic momentum, the numbers investors actually trade on remain stubborn. Revenue in the second quarter of 2026 flatlined at $3.1 million year over year. Across the entire first half, sales tumbled 67% to $5.9 million, measured against a demanding comparison created by a large system sale in the prior year.
Bookings tell the opposite story. First-half 2026 bookings surged 1,120% to $35.5 million, buoyed by a single system sale exceeding $20 million. That divergence funnels the entire year into the fourth quarter: management is sticking to its forecast of shipping two systems in the full year and has guided that the bulk of annual revenue will land in the final three months. Missing that commitment precisely would put investor confidence at risk.
A CFO Departure and a Stock Under Pressure
The transition has not been frictionless. CFO John Markovich stepped down on September 2 after five years with the company, leaving Greg Golkov to run the finance function in an acting capacity — an awkward handoff during a period when execution credibility matters most.
The equity has felt the strain. Since the start of the year, the stock has shed 37%, and in pre-market trading today it changed hands at EUR 14.30, a modest gain of 0.8%. The 52-week low sits at EUR 11.12.
Two Dates That Matter
The bull case rests on a clean handoff from backlog to revenue. If Schoelkopf can convincingly connect error-corrected gate systems with the operational use of annealing machines, and if both system deliveries land in the fourth quarter without a hitch, the $35.5 million order book converts into a visible revenue step-up — and the shares could mount a durable recovery.
The bear case writes itself from the same facts. Complex hardware installations slip. If one of the two systems fails to install or its acceptance slides into 2027, the full-year plan misses. Should the Maryland presentation fall flat on top of that, a retest of the 52-week low of EUR 11.12 becomes the path of least resistance.
Two appointments will settle the argument. The plenary address on September 25 must demonstrate the operating value of the Quantum Circuits acquisition. Then, on November 5, 2026, D-Wave reports third-quarter results and will have to show how far preparations for the revenue-critical year-end push have actually progressed.
Ad
D-Wave Quantum Stock: New Analysis - 16 September
Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
